Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2024-09-04 00:00:00 ET · period of report 2024-07-15 · accession 0001415889-24-022854 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-04 | 2024-07-15 | KNSA | Moat Ross | Chief COMMERCIAL Off | A - Grant | $15.65 | +211 | 18.4K | +1% | +$3,302 |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Moat Ross | Chief COMMERCIAL Off | M - OptEx | $10.95 | +73.6K | 22.5K | New | +$805.9K |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Moat Ross | Chief COMMERCIAL Off | F - Tax | $26.74 | -1,738 | 21.7K | -7% | -$46.5K |
| DM | 2024-09-04 | 2024-09-03 | KNSA | Moat Ross | Chief COMMERCIAL Off | S - Sale+OE | $26.12 | -68.5K | 22.9K | -75% | -$1.79M |
| DM | 2024-09-04 | 2024-09-01 | KNSA | Moat Ross | Chief COMMERCIAL Off | A - Grant | $0.00 | +43.1K | 6,962 | New | $0 |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Moat Ross | Chief COMMERCIAL Off | M - OptEx | $0.00 | -73.6K | 4,833 | -94% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2024-07-15 | A | A | 211 | $15.65 | 18,391 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2024-09-03 | M | A | 24,776 | $11.97 | 90,242 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2024-09-01 | F | D | 1,393 | $26.74 | 21,087 | D | — | — | |
| 4 | Common | Class A Ordinary Share | 2024-09-02 | M | A | 994 | — | 22,081 | D | — | — | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 5 | Common | Class A Ordinary Share | 2024-09-02 | F | D | 345 | $26.74 | 21,736 | D | — | — | |
| 6 | Common | Class A Ordinary Share | 2024-09-03 | M | A | 14,000 | $8.83 | 35,736 | D | — | — | |
| 7 | Common | Class A Ordinary Share | 2024-09-03 | M | A | 29,730 | $11.10 | 65,466 | D | — | — | |
| 8 | Common | Class A Ordinary Share | 2024-09-03 | S | D | 1,160 | $27.12 | 21,736 | D | — | — | (F5) This transaction was executed in multiple trades through a broker-dealer at prices ranging from $26.995 to $27.18. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 9 | Common | Class A Ordinary Share | 2024-09-03 | S | D | 67,346 | $26.10 | 22,896 | D | — | — | (F4) This transaction was executed in multiple trades through a broker-dealer at prices ranging from $25.88 to $26.80. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 10 | Common | Class A Ordinary Share | 2024-09-01 | M | A | 4,089 | — | 22,480 | D | — | — | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 11 | Derivative | Share Option | 2024-09-01 | A | A | 36,100 | $0.00 | 36,100 | D | $26.74 · — to 2034-08-31 | 36,100 Class A Ordinary Share | (F7) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2024. |
| 12 | Derivative | Restricted Share Unit | 2024-09-01 | M | D | 2,477 | $0.00 | 4,954 | D | — · — to — | 2,477 Class A Ordinary Share | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F8) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022. |
| 13 | Derivative | Share Option | 2024-09-03 | M | D | 24,776 | $0.00 | 30,924 | D | $11.97 · — to 2032-08-31 | 24,776 Class A Ordinary Share | (F13) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2022. |
| 14 | Derivative | Restricted Share Unit | 2024-09-02 | M | D | 994 | $0.00 | 994 | D | — · — to — | 994 Class A Ordinary Share | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F10) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the vesting commencement date September 2, 2021. |
| 15 | Derivative | Share Option | 2024-09-03 | M | D | 14,000 | $0.00 | 0 | D | $8.83 · — to 2029-09-16 | 14,000 Class A Ordinary Share | (F11) The option is fully vested and exercisable. |
| 16 | Derivative | Share Option | 2024-09-03 | M | D | 29,730 | $0.00 | 18,534 | D | $11.10 · — to 2032-04-06 | 29,730 Class A Ordinary Share | (F12) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 7, 2022. |
| 17 | Derivative | Restricted Share Unit | 2024-09-01 | A | A | 6,962 | $0.00 | 6,962 | D | — · — to — | 6,962 Class A Ordinary Share | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F6) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024. |
| 18 | Derivative | Restricted Share Unit | 2024-09-01 | M | D | 1,612 | $0.00 | 4,833 | D | — · — to — | 1,612 Class A Ordinary Share | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F9) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023. |